Nick Goeden
Chief Science Officer
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Nick Goeden is the Chief Science Officer at Asymptote Genetic Medicines in the United States. His research focuses on adeno-associated viral (AAV) vectors and their applications in gene transfer, particularly within the non-human primate brain and nervous system. He has contributed to numerous publications that explore advancements in AAV technology and its implications for therapeutic delivery, as well as the use of ketamine infusion in critical care settings.
Articles (6)
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2021
Year:
2020
Collaborators (4)
Min Jee Jang
Assistant Professor
University of Illinois at Urbana-Champaign
Qi Wang
University of Minnesota
Katherine Ferrara
Professor
Stanford University
EDUARDO A. SILVA
Associated Professor (with Tenure)
University of California, Davis
Make your next move.
Prepare your application
Review drafts before you send them.